{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T20:31:53Z","timestamp":1774816313907,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018530","name":"Major Science and Technology Projects in Anhui Province","doi-asserted-by":"publisher","award":["2020b07050001"],"award-info":[{"award-number":["2020b07050001"]}],"id":[{"id":"10.13039\/501100018530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["12126604"],"award-info":[{"award-number":["12126604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"R&D project of Pazhou Lab","award":["Grant2023K0609"],"award-info":[{"award-number":["Grant2023K0609"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"DOI":"10.1186\/s12859-024-05897-1","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T05:01:59Z","timestamp":1726203719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel approach to the analysis of Overall Survival (OS) as response with Progression-Free Interval (PFI) as condition based on the RNA-seq expression data in The Cancer Genome Atlas (TCGA)"],"prefix":"10.1186","volume":"25","author":[{"given":"Bo","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"issue":"15","key":"5897_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","volume":"25","author":"CA Hudis","year":"2007","unstructured":"Hudis CA, Barlow WE, Costantino JP. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol. 2007;25(15):2127\u201332.","journal-title":"J Clin Oncol"},{"issue":"13","key":"5897_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/jnci\/djm024","volume":"99","author":"CJA Punt","year":"2007","unstructured":"Punt CJA, Buyse M, K\u00f6hne C. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007;99(13):998\u20131003.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5897_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"R David Cox","year":"1972","unstructured":"David Cox R, David R. Regression models and life tables. J Roy Stat Soc. 1972;34(2):187\u2013220.","journal-title":"J Roy Stat Soc"},{"issue":"1","key":"5897_CR4","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1038\/s41598-017-10559-9","volume":"7","author":"HY Xie","year":"2017","unstructured":"Xie HY, Wang WJ, Sun FY, et al. Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer. Sci Rep. 2017;7(1):9896.","journal-title":"Sci Rep"},{"key":"5897_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103286","volume":"98","author":"O Lyudovyk","year":"2019","unstructured":"Lyudovyk O, Shen YF, Tatonetti NP, et al. Pathway analysis of genomic pathology tests for prognostic cancer subtyping. J Biomed Inform. 2019;98: 103286.","journal-title":"J Biomed Inform"},{"issue":"4","key":"5897_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1470-2045(09)70023-3","volume":"10","author":"S Michiels","year":"2009","unstructured":"Michiels S, Le MA, Buyse M, et al. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. Lancet Oncol. 2009;10(4):341\u201350.","journal-title":"Lancet Oncol"},{"issue":"6","key":"5897_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/0962280211425578","volume":"24","author":"V Rondeau","year":"2015","unstructured":"Rondeau V, Pignon JP, Michiels S. A joint model for the dependence between clustered times to tumour progression and deaths: a meta-analysis of chemotherapy in head and neck cancer. Stat Methods Med Res. 2015;24(6):711\u201329.","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"5897_CR8","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1177\/0962280215604510","volume":"26","author":"T Emura","year":"2017","unstructured":"Emura T, Nakatochi M, Murotani K, et al. A joint frailty-copula model between tumour progression and death for meta-analysis. Stat Methods Med Res. 2017;26(6):2649\u201366.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"5897_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/biomet\/84.1.45","volume":"84","author":"R Day","year":"1997","unstructured":"Day R, Bryant J, Lefkopoulou M. Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators. Biometrika. 1997;84(1):45\u201356.","journal-title":"Biometrika"},{"issue":"4","key":"5897_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<563::AID-SIM356>3.0.CO;2-K","volume":"19","author":"R Henderson","year":"2000","unstructured":"Henderson R, Prince H. Choice of conditional models in bivariate survival. Stat Med. 2000;19(4):563\u201374.","journal-title":"Stat Med"},{"key":"5897_CR11","volume-title":"The frailty model","author":"L Duchateau","year":"2008","unstructured":"Duchateau L, Janssen P. The frailty model. Berlin: Springer; 2008."},{"issue":"5","key":"5897_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/03610920903480882","volume":"40","author":"SOM Manda","year":"2011","unstructured":"Manda SOM. A nonparametric frailty model for clustered survival data. Commun Stat-Theory Methods. 2011;40(5):863\u201375.","journal-title":"Commun Stat-Theory Methods"},{"issue":"3","key":"5897_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/biostatistics\/kxy071","volume":"21","author":"F Gasperoni","year":"2020","unstructured":"Gasperoni F, Ieva F, Paganoni AM, et al. Non-parametric frailty Cox models for hierarchical time-to-event data. Biostatistics. 2020;21(3):531\u201344.","journal-title":"Biostatistics"},{"key":"5897_CR14","doi-asserted-by":"crossref","unstructured":"Rogoz B, de l\u2019Aulnoit A H, Duhamel A, et al. Thirty-year trends of survival and time-varying effects of prognostic factors in patients with metastatic breast cancer\u2014a single institution experience. Clin Breast Cancer. 2018;18(3):246\u201353.","DOI":"10.1016\/j.clbc.2017.08.012"},{"key":"5897_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/2529977","volume":"1","author":"MH Gail","year":"1980","unstructured":"Gail MH, Santner TJ, Brown CC. An analysis of comparative carcinogenesis experiments based on multiple times to tumor. Biometrics. 1980;1:255\u201366.","journal-title":"Biometrics"},{"key":"5897_CR16","first-page":"1","volume":"1","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;1:1.","journal-title":"BMC Bioinf"},{"issue":"2","key":"5897_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56(2):337\u201344.","journal-title":"Biometrics"},{"issue":"1","key":"5897_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61(1):92\u2013105.","journal-title":"Biometrics"},{"issue":"30","key":"5897_CR19","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32(30):5381\u201397.","journal-title":"Stat Med"},{"issue":"1","key":"5897_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","volume":"20","author":"LD Fisher","year":"1999","unstructured":"Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health. 1999;20(1):145\u201357.","journal-title":"Annu Rev Public Health"},{"key":"5897_CR21","unstructured":"Mwikali\u00a0Muli A, Houwing-Duistermaat J, Gusnanto A. Use of shared gamma frailty model in analysis of survival data in twins.  Use of Shared Gamma Frailty Model in Analysis of Survival Data in Twins, 2021; pp. 45\u201358."},{"issue":"1","key":"5897_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12029-021-00775-y","volume":"54","author":"LM Esayas","year":"2023","unstructured":"Esayas LM, Akessa GM, Kifle DD. Application of parametric shared frailty models to analyze time-to-death of gastric cancer patients. J Gastrointest Cancer. 2023;54(1):104\u201316.","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"5897_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K. PGC-1$$\\alpha$$-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267\u201373.","journal-title":"Nat Genet"},{"issue":"43","key":"5897_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha V. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"issue":"282","key":"5897_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"Edward L Kaplan","year":"1958","unstructured":"Kaplan Edward L, Meier Paul. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457\u201381.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"5897_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"JF Liu","year":"2018","unstructured":"Liu JF, Lichtenberg T, Hoadley KA. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400\u201316.","journal-title":"Cell"},{"issue":"7971","key":"5897_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41586-023-06253-8","volume":"619","author":"AM Kaiser","year":"2023","unstructured":"Kaiser AM, Gatto A, Hanson KJ. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature. 2023;619(7971):851\u20139.","journal-title":"Nature"},{"issue":"7","key":"5897_CR28","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/nar\/gkw036","volume":"44","author":"AC Bretz","year":"2016","unstructured":"Bretz AC, Gittler MP, Charles JP. $$\\Delta$$Np63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma. Nucl Acids Res. 2016;44(7):3204\u201318.","journal-title":"Nucl Acids Res"},{"issue":"1","key":"5897_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12885-023-11646-z","volume":"24","author":"W Liu","year":"2024","unstructured":"Liu W, Du Q, Mei T. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma. BMC Cancer. 2024;24(1):94.","journal-title":"BMC Cancer"},{"issue":"9","key":"5897_CR30","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/15384101.2022.2035617","volume":"21","author":"G Ye","year":"2022","unstructured":"Ye G, Luo H, Zhang T. Knockdown of RNF183 suppressed proliferation of lung adenocarcinoma cells via inactivating the STAT3 signaling pathway. Cell Cycle. 2022;21(9):948\u201360.","journal-title":"Cell Cycle"},{"key":"5897_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110350","volume":"95","author":"SD Precilla","year":"2022","unstructured":"Precilla SD, Biswas I, Kuduvalli SS. Crosstalk between PI3K\/AKT\/mTOR and WNT\/$$\\beta$$-Catenin signaling in GBM-Could combination therapy checkmate the collusion? Cell Signal. 2022;95: 110350.","journal-title":"Cell Signal"},{"key":"5897_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5308-y","volume":"19","author":"S Heynckes","year":"2019","unstructured":"Heynckes S, Daka K, Franco P. Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme. BMC Cancer. 2019;19:1\u20137.","journal-title":"BMC Cancer"},{"issue":"5\u20136","key":"5897_CR33","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1002\/jcb.29577","volume":"121","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, He J, Guo Y. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis. J Cell Biochem. 2020;121(5\u20136):3099\u2013111.","journal-title":"J Cell Biochem"},{"issue":"5","key":"5897_CR34","first-page":"4369","volume":"17","author":"X Zan","year":"2019","unstructured":"Zan X, Li L. Construction of lncRNA-mediated ceRNA network to reveal clinically relevant lncRNA biomarkers in glioblastomas. Oncol Lett. 2019;17(5):4369\u201374.","journal-title":"Oncol Lett"},{"issue":"3","key":"5897_CR35","first-page":"3399","volume":"18","author":"F Alowaidi","year":"2019","unstructured":"Alowaidi F, Hashimi SM, Alqurashi N. Cripto-1 overexpression in U87 glioblastoma cells activates MAPK, focal adhesion and ErbB pathways. Oncol Lett. 2019;18(3):3399\u2013406.","journal-title":"Oncol Lett"},{"key":"5897_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117600","volume":"253","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao H, Chen J. Mining database for the expression and gene regulation network of JAK2 in skin cutaneous melanoma. Life Sci. 2020;253: 117600.","journal-title":"Life Sci"},{"issue":"1","key":"5897_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10637-023-01413-z","volume":"42","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Hu X, Wang Z. RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma. Invest New Drugs. 2024;42(1):60\u20139.","journal-title":"Invest New Drugs"},{"issue":"3","key":"5897_CR38","first-page":"1","volume":"2","author":"T Therneau","year":"2017","unstructured":"Therneau T, Crowson C, Atkinson E. Using time dependent covariates and time dependent coefficients in the Cox model. Surv Vignettes. 2017;2(3):1\u201325.","journal-title":"Surv Vignettes"},{"key":"5897_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2016.05.016","volume":"65","author":"T Hamada","year":"2016","unstructured":"Hamada T, Nakai Y, Isayama H, et al. Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer. Eur J Cancer. 2016;65:11\u201320.","journal-title":"Eur J Cancer"},{"issue":"33","key":"5897_CR40","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1200\/JCO.2007.11.8836","volume":"25","author":"M Buyse","year":"2007","unstructured":"Buyse M, Burzykowski T, Carroll K, et al. Progression-free survival is a surrogate for survival in advanced colorectal cancer. J Clin Oncol. 2007;25(33):5218\u201324.","journal-title":"J Clin Oncol"},{"key":"5897_CR41","unstructured":"Ma\u00a0Y. Flexible isotonic regression in survival data analysis. PhD thesis, The George Washington University, 2010."},{"key":"5897_CR42","doi-asserted-by":"publisher","DOI":"10.1201\/b10510","volume-title":"Modeling survival data using frailty models","author":"DD Hanagal","year":"2011","unstructured":"Hanagal DD. Modeling survival data using frailty models. Berlin: Springer; 2011."},{"issue":"2","key":"5897_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/08898489509525394","volume":"5","author":"AI Yashin","year":"1995","unstructured":"Yashin AI, Vaupel JW, Iachine IA. Correlated individual frailty: an advantageous approach to survival analysis of bivariate data. Math Popul Stud. 1995;5(2):145\u201359.","journal-title":"Math Popul Stud"},{"key":"5897_CR44","doi-asserted-by":"crossref","unstructured":"Wienke A. Frailty models in survival analysis. Chapman and Hall\/CRC, 2010.","DOI":"10.1201\/9781420073911"},{"issue":"10\u201311","key":"5897_CR45","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1177\/0962280218803127","volume":"28","author":"A Martins","year":"2019","unstructured":"Martins A, Aerts M, Hens N, et al. Correlated gamma frailty models for bivariate survival time data. Stat Methods Med Res. 2019;28(10\u201311):3437\u201350.","journal-title":"Stat Methods Med Res"},{"key":"5897_CR46","first-page":"1","volume":"1","author":"SK Ng","year":"2021","unstructured":"Ng SK, Tawiah R, Mclachlan GJ, et al. Joint frailty modeling of time-to-event data to elicit the evolution pathway of events: a generalized linear mixed model approach. Biostatistics. 2021;1:1.","journal-title":"Biostatistics"},{"issue":"2","key":"5897_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10985-017-9396-1","volume":"24","author":"JS Romeo","year":"2018","unstructured":"Romeo JS, Meyer R, Gallardo DI. Bayesian bivariate survival analysis using the power variance function copula. Lifetime Data Anal. 2018;24(2):355\u201383.","journal-title":"Lifetime Data Anal"},{"key":"5897_CR48","doi-asserted-by":"crossref","unstructured":"Emura T, Matsui S, Rondeau V. Survival analysis with correlated endpoints: Joint Frailty-Copula models. Springer; 2019.","DOI":"10.1007\/978-981-13-3516-7"},{"issue":"2","key":"5897_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/bimj.201900306","volume":"63","author":"CL Sofeu","year":"2021","unstructured":"Sofeu CL, Emura T, Rondeau V. A joint frailty-copula model for meta-analytic validation of failure time surrogate endpoints in clinical trials. Biom J. 2021;63(2):423\u201346.","journal-title":"Biom J"},{"issue":"1","key":"5897_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.0006-341X.2000.00199.x","volume":"56","author":"W Pan","year":"2000","unstructured":"Pan W. A multiple imputation approach to Cox regression with interval-censored data. Biometrics. 2000;56(1):199\u2013203.","journal-title":"Biometrics"},{"issue":"6","key":"5897_CR51","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/sim.3835","volume":"29","author":"KF Lam","year":"2010","unstructured":"Lam KF, Xu Y, Cheung TL. A multiple imputation approach for clustered interval-censored survival data. Stat Med. 2010;29(6):680\u201393.","journal-title":"Stat Med"},{"issue":"3","key":"5897_CR52","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.0006-341X.2000.00940.x","volume":"56","author":"WB Goggins","year":"2000","unstructured":"Goggins WB, Finkelstein DM. A proportional hazards model for multivariate interval-censored failure time data. Biometrics. 2000;56(3):940\u20133.","journal-title":"Biometrics"},{"issue":"23","key":"5897_CR53","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1002\/sim.1265","volume":"21","author":"MY Kim","year":"2002","unstructured":"Kim MY, Xue X. The analysis of multivariate interval-censored survival data. Stat Med. 2002;21(23):3715\u201326.","journal-title":"Stat Med"},{"issue":"23","key":"5897_CR54","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1002\/sim.1918","volume":"23","author":"SL Bellamy","year":"2004","unstructured":"Bellamy SL, Li Y, Ryan LM, et al. Analysis of clustered and interval censored data from a community-based study in asthma. Stat Med. 2004;23(23):3607\u201321.","journal-title":"Stat Med"},{"issue":"9","key":"5897_CR55","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/154405910508400907","volume":"84","author":"MCM Wong","year":"2005","unstructured":"Wong MCM, Lam KF, Lo ECM. Bayesian analysis of clustered interval-censored data. J Dent Res. 2005;84(9):817\u201321.","journal-title":"J Dent Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-024-05897-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-024-05897-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-024-05897-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T05:02:23Z","timestamp":1726203743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-024-05897-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5897"],"URL":"https:\/\/doi.org\/10.1186\/s12859-024-05897-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"assertion":[{"value":"13 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the established guidelines of TCGA and UCSC, consequently, the requirement for ethical approval and patient informed consent was waived (https:\/\/xenabrowser. net\/datapages\/).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"300"}}